activity of bone cells from nasal septum and their use to perform accurate molecular analysis from a single sample. METHOD: The cells, collected during nasal septum surgery (from a total of 81 patients), were subsequently subjected to gene silencing, Reverse Transcriptase Polymerase Chain reactions, immunocytochemistry, and Chromatin Immunoprecipitation experiments. RESULTS: The cells gave rise to mature osteoblasts expressing osteogenic markers (ALP, Runx2, Slug) and were able to mineralize. For the first time, we demonstrated that Runx2, a marker of early osteospecific differentiation, interacts in vivo with promoter of SLUG gene, a marker of osteoblast maturation, indicating an important correlation between the pathways mediated by these two transcription factors. CONCLUSION: We demonstrated that nasal septum-derived osteoblasts can be an ideal, unique, easily accessible, noncontroversial alternative source for osteoblasts, due to the simple collection procedure during nasal septum surgery once bone tissue is routinely discharged. The ability to proliferate and to differentiate into mature osteoblasts at the same time, makes the use of these cells particularly attractive both for the research addressed to new molecular targets detection, and the development of therapeutic strategies aimed to repair and replace damaged tissues. At the same time, we demonstrated that, from a single sample, it is possible to obtain a sufficient quantity to perform several molecular analysis including RT-PCR, Chromatin immunoprecipitation, and immunocytochemical experiments.
Outpatient Bridging of Anticoagulation for Tonsillectomy
Adam Holdt, MD (presenter); Julie Goddard, MD OBJECTIVE: Tonsillectomy, with its unique risk of primary and secondary hemorrhage, is rarely performed in patients on long-term warfarin anticoagulation. The objectives of this study are to review the literature regarding management of perioperative anticoagulation therapy and to present an outpatient strategy of perioperative anticoagulation bridging for tonsillectomy using low molecular weight heparin (LMWH). METHOD: A literature search regarding guidelines for perioperative anticoagulation was performed. A case report is presented of a 29-year-old male on chronic warfarin for a mechanical mitral valve who underwent tonsillectomy. The patient has a history of mitral valve replacement due to endocarditis after an episode of Streptococcal tonsillitis. The patient's perioperative anticoagulation plan utilized LMWH therapy. He stopped warfarin and began LMWH five days prior to surgery, holding this 24 hours prior to surgery. He resumed LMWH postoperative day 3 and warfarin postoperative day 7, continuing both until reaching therapeutic INR. RESULTS: Tonsillectomy in an anticoagulated patient has previously been described once, and there are no guidelines for perioperative anticoagulation for this procedure. This patient managed his anticoagulation from home and successfully underwent surgery. He did not experience adverse events, did not require an extended inpatient stay, and is doing well 3 months postoperatively. CONCLUSION: Tonsillectomy can be performed successfully in an anticoagulated patient with outpatient LMWH bridging. A strategy for perioperative anticoagulation that accounts for the risk of secondary bleeding after tonsillectomy should be utilized. A larger cohort of patients would help elucidate the risk of adverse events with tonsillectomy in this patient population.
Postoperative Hemorrhage Following Coblation Tonsillectomy
Jason Siew Yoong Hwang, MBBS, FRCS (presenter) OBJECTIVE: This study aims: 1) To review the incidence of postoperative hemorrhage following coblation tonsillectomy.
2) To determine the correlation between surgeon grade and bleeding rates. 3) To determine if surgical time and postoperative hemorrhage are reduced after increased experience with coblation. METHOD: A retrospective review of 324 consecutive adult coblation tonsillectomies performed from January 2004 to December 2008 was done to assess for postoperative bleeding. Bleeding was divided into primary and secondary hemorrhage, then subanalyzed by surgeon grade (consultant, senior resident and junior resident). Surgical time was also reviewed. RESULTS: The postoperative hemorrhage rate for coblation tonsillectomy was 11.4% (37/324). Of these 37 cases, there were 6 primary bleeds and 31 secondary bleeds. Majority of these episodes resolved with conservative treatment. Only 6 cases (1.9%) required hemostasis under general anesthesia. Junior residents had the highest overall postoperative hemorrhage rate amongst the surgeons(17.4%). Subanalysis showed consultants had the highest proportion of primary bleeds (4 of 6 cases) whilst senior residents had the highest proportion of secondary bleeds (15 of 31 cases). Analysis by year did not show any significant trend in postoperative hemorrhage rates (pϭ .87). No reduction in average operating time was observed over the 5 year review period (pϭ.98). CONCLUSION: Our postoperative hemorrhage rate of 11.4% is comparable with recent literature. A higher proportion of cases performed by junior surgeons developed postoperative bleeding. We believe this is due to limited exposure and training with coblation. Increased experience with coblation does not translate into faster operating time.
